BioAtla
phase study design with | BioAtla
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
18 of 44
Similar slides by BioAtla
See diffirences between slides (animation)
Investor Presentation
August 2023
phase study design with | BioAtla
Investor Presentation
November 2022
phase study design with in refractory patients | BioAtla
Investor Presentation
November 2022
phase study design with | BioAtla
Investor Presentation
August 2022
phase study design with in refractory patients | BioAtla
Related slides by other companies
Anebulo Pharmaceuticals
Investor Day
September 2022
phase part adaptive study design | Anebulo Pharmaceuticals
ATAI
Investor Presentation
January 2024
trial status first patient dosed in topline data anticipated mid clinical design phase study | ATAI
Ocuphire Pharma
Results
June 2021
presbyopia phase design | Ocuphire Pharma
NeuroBo Pharmaceuticals
Securities Offering
October 2022
nash upcoming study overview phase to establish signal efficacy in nash a | NeuroBo Pharmaceuticals
Other recent decks by BioAtla
See all presentations (8 decks)
Investor Presentation
January 2024
Investor Presentation
August 2023
Investor Presentation
November 2022
Investor Presentation
August 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io